| __timestamp | Corcept Therapeutics Incorporated | Exelixis, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 26551000 | 25111000 |
| Thursday, January 1, 2015 | 50286000 | 37172000 |
| Friday, January 1, 2016 | 81321000 | 191454000 |
| Sunday, January 1, 2017 | 159201000 | 452477000 |
| Monday, January 1, 2018 | 251247000 | 853826000 |
| Tuesday, January 1, 2019 | 306486000 | 967775000 |
| Wednesday, January 1, 2020 | 353874000 | 987538000 |
| Friday, January 1, 2021 | 365978000 | 1434970000 |
| Saturday, January 1, 2022 | 401858000 | 1611062000 |
| Sunday, January 1, 2023 | 482375000 | 1830208000 |
| Monday, January 1, 2024 | 2168701000 |
Unleashing insights
In the competitive landscape of biotechnology, Exelixis, Inc. and Corcept Therapeutics Incorporated have shown remarkable revenue growth over the past decade. Since 2014, Exelixis has seen its revenue skyrocket by over 7,200%, reaching approximately $1.83 billion in 2023. This impressive growth is largely attributed to its successful oncology products. Meanwhile, Corcept Therapeutics has also experienced significant growth, with its revenue increasing by nearly 1,700% to around $482 million in the same period, driven by its niche focus on metabolic disorders.
Both companies have demonstrated resilience and strategic prowess in navigating the biotech sector's challenges. While Exelixis leads in absolute revenue, Corcept's steady growth highlights its potential in specialized markets. As we look to the future, these companies' trajectories offer valuable insights into the evolving dynamics of the biotech industry.
Comparing Revenue Performance: AstraZeneca PLC or Exelixis, Inc.?
Breaking Down Revenue Trends: Zoetis Inc. vs Exelixis, Inc.
Teva Pharmaceutical Industries Limited vs Corcept Therapeutics Incorporated: Examining Key Revenue Metrics
Who Generates More Revenue? Dr. Reddy's Laboratories Limited or Exelixis, Inc.
Breaking Down Revenue Trends: Dr. Reddy's Laboratories Limited vs Corcept Therapeutics Incorporated
Exelixis, Inc. and Amneal Pharmaceuticals, Inc.: A Comprehensive Revenue Analysis
Cost Management Insights: SG&A Expenses for Exelixis, Inc. and Corcept Therapeutics Incorporated
Jazz Pharmaceuticals plc and Corcept Therapeutics Incorporated: A Comprehensive Revenue Analysis
Revenue Insights: Grifols, S.A. and Corcept Therapeutics Incorporated Performance Compared
Revenue Insights: Corcept Therapeutics Incorporated and Veracyte, Inc. Performance Compared
Corcept Therapeutics Incorporated vs Merus N.V.: Examining Key Revenue Metrics
Corcept Therapeutics Incorporated vs Evotec SE: Annual Revenue Growth Compared